MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The PRIME Qual study protocol: A qualitative exploration of the experiences of patients, caregivers/families and hospital/intervention staff of the PRIME Randomised Controlled Trial

H. Brant, E. Henderson, D. Gervaise-Brazier, F. Lithander, E. Tenison, S. Redwood (Bristol, United Kingdom)

Meeting: MDS Virtual Congress 2021

Abstract Number: 636

Keywords: Parkinson’s

Category: Parkinson's Disease and Lewy Body Dementia

Objective: This qualitative study seeks to  understand how a new model of care influences a person with Parkinson’s ability to stay well physically, maintain their psycho-social state and to manage their own disease

Background: People living with Parkinson’s and their families and caregivers can face a multitude of different clinical, physical, emotional and social challenges. A new model, termed PRIME Parkinson (Proactive and Integrated Management and Empowerment in Parkinson’s) has been developed to manage problems proactively and to deliver integrated, multidisciplinary care. This will be through: 1) personalised care management, 2) education and empowerment of patients and carers, 3) empowerment of healthcare professionals, and 4) technological support of the previous three components. The aim is to personalise care to the individual’s needs and priorities including additional support based around exercise, healthy eating, sleep or medication, depending what is relevant and most important to them.

Method: This is a qualitative study embedded within a randomised control trial (PRIME RCT) where participants will be allocated to receive usual care or the PRIME model of care for two years in the UK. Semi-structured interviews will be conducted to explore and understand the experiences of living with Parkinson’s in patients and caregivers enrolled onto both arms of the RCT at three time points; at baseline, one year and two years later. We will also interview hospital staff involved in the care of people with Parkinson’s alongside staff involved in the delivery of the intervention.

Results: The qualitative study will provide insight into the ways in which any positive effects of PRIME Parkinson’s care are mediated across the four domains. The transcripts will be analysed inductively and iteratively using thematic analysis. Coding will occur concurrently and iteratively using the constant comparative method.

Conclusion: The qualitative study findings will be synthesised with the findings from the RCT to understand the mechanisms by which the intervention works or does not work. This will provide vital and fundamental knowledge that will inform the scalability of the programme.

To cite this abstract in AMA style:

H. Brant, E. Henderson, D. Gervaise-Brazier, F. Lithander, E. Tenison, S. Redwood. The PRIME Qual study protocol: A qualitative exploration of the experiences of patients, caregivers/families and hospital/intervention staff of the PRIME Randomised Controlled Trial [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/the-prime-qual-study-protocol-a-qualitative-exploration-of-the-experiences-of-patients-caregivers-families-and-hospital-intervention-staff-of-the-prime-randomised-controlled-trial/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-prime-qual-study-protocol-a-qualitative-exploration-of-the-experiences-of-patients-caregivers-families-and-hospital-intervention-staff-of-the-prime-randomised-controlled-trial/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley